126 related articles for article (PubMed ID: 29160535)
21. Expression of alpha- and beta-defensins in human ocular surface tissue.
Ikeda A; Sakimoto T; Shoji J; Sawa M
Jpn J Ophthalmol; 2005; 49(2):73-8. PubMed ID: 15838720
[TBL] [Abstract][Full Text] [Related]
22. Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease.
Narayanan S; Miller WL; McDermott AM
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3795-801. PubMed ID: 12939294
[TBL] [Abstract][Full Text] [Related]
23. Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus.
Gambichler T; Skrygan M; Tigges C; Kobus S; Gläser R; Kreuter A
Br J Dermatol; 2009 Nov; 161(5):1136-42. PubMed ID: 19558556
[TBL] [Abstract][Full Text] [Related]
24. Expression of prostaglandin E
Dinç E; Dursun Ö; Yılmaz B; Vatansever M; Sarı AA; Yıldırım Ö; Adıgüzel U
Int Ophthalmol; 2018 Aug; 38(4):1703-1708. PubMed ID: 28695379
[TBL] [Abstract][Full Text] [Related]
25. The RLR/NLR expression and pro-inflammatory activity of tissue mast cells are regulated by cathelicidin LL-37 and defensin hBD-2.
Agier J; Różalska S; Wiktorska M; Żelechowska P; Pastwińska J; Brzezińska-Błaszczyk E
Sci Rep; 2018 Aug; 8(1):11750. PubMed ID: 30082780
[TBL] [Abstract][Full Text] [Related]
26. Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of atopic individuals.
Goo J; Ji JH; Jeon H; Kim MJ; Jeon SY; Cho MY; Lee SH; Choi EH
Pediatr Dermatol; 2010; 27(4):341-8. PubMed ID: 20653851
[TBL] [Abstract][Full Text] [Related]
27. Increased serum antimicrobial peptide LL-37 and HBD-2 combined with 25-hydroxyvitamin D3 deficiency in infants with pertussis.
Chen S; Ye W; Zheng W; Xu Z; Chen Y; Jin L
J Infect Dev Ctries; 2020 Oct; 14(10):1164-1169. PubMed ID: 33175712
[TBL] [Abstract][Full Text] [Related]
28. Identification and quantification of innate immune system mediators in human breast milk.
Armogida SA; Yannaras NM; Melton AL; Srivastava MD
Allergy Asthma Proc; 2004; 25(5):297-304. PubMed ID: 15603202
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical profile of VEGF, TGF-β and PGE₂ in human pterygium and normal conjunctiva: experimental study and review of the literature.
Bianchi E; Scarinci F; Grande C; Plateroti R; Plateroti P; Plateroti AM; Fumagalli L; Capozzi P; Feher J; Artico M
Int J Immunopathol Pharmacol; 2012; 25(3):607-15. PubMed ID: 23058011
[TBL] [Abstract][Full Text] [Related]
30. Expression of Antimicrobial Peptides in Human Monocytic Cells and Neutrophils in Response to Dengue Virus Type 2.
Castañeda-Sánchez JI; Domínguez-Martínez DA; Olivar-Espinosa N; García-Pérez BE; Loroño-Pino MA; Luna-Herrera J; Salazar MI
Intervirology; 2016; 59(1):8-19. PubMed ID: 27318958
[TBL] [Abstract][Full Text] [Related]
31. Modulation of toll-like receptor 7 and LL-37 expression in colon and breast epithelial cells by human beta-defensin-2.
Stroinigg N; Srivastava MD
Allergy Asthma Proc; 2005; 26(4):299-309. PubMed ID: 16270724
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.
Chen X; Niyonsaba F; Ushio H; Okuda D; Nagaoka I; Ikeda S; Okumura K; Ogawa H
J Dermatol Sci; 2005 Nov; 40(2):123-32. PubMed ID: 15963694
[TBL] [Abstract][Full Text] [Related]
33. Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion.
Laudien M; Dressel S; Harder J; Gläser R
Rhinology; 2011 Mar; 49(1):107-11. PubMed ID: 21468384
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial peptides in nasal secretion and mucosa with respect to S. aureus colonisation in Wegener´s granulomatosis.
Hui Y; Wohlers J; Podschun R; Hedderich J; Lamprecht P; Ambrosch P; Laudien M
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S49-56. PubMed ID: 21470491
[TBL] [Abstract][Full Text] [Related]
35. Comparison of TLR-2, TLR-4, and antimicrobial peptide levels in different lesions of acne vulgaris.
Ozlu E; Karadag AS; Ozkanli S; Oguztuzun S; Kilic M; Zemheri E; Akbulak O; Akdeniz N
Cutan Ocul Toxicol; 2016 Dec; 35(4):300-9. PubMed ID: 26695933
[TBL] [Abstract][Full Text] [Related]
36. Relative quantification of human β‑defensins gene expression in pterygium and normal conjunctiva samples.
Abubakar SA; Isa MM; Omar N; Tan SW
Mol Med Rep; 2020 Dec; 22(6):4931-4937. PubMed ID: 33174018
[TBL] [Abstract][Full Text] [Related]
37. Production of beta-defensin antimicrobial peptides by maxillary sinus mucosa.
Carothers DG; Graham SM; Jia HP; Ackermann MR; Tack BF; McCray PB
Am J Rhinol; 2001; 15(3):175-9. PubMed ID: 11453504
[TBL] [Abstract][Full Text] [Related]
38. Expression and activity of beta-defensins and LL-37 in the developing human lung.
Starner TD; Agerberth B; Gudmundsson GH; McCray PB
J Immunol; 2005 Feb; 174(3):1608-15. PubMed ID: 15661923
[TBL] [Abstract][Full Text] [Related]
39. Expression of antimicrobial peptides in diabetic foot ulcer.
Rivas-Santiago B; Trujillo V; Montoya A; Gonzalez-Curiel I; Castañeda-Delgado J; Cardenas A; Rincon K; Hernandez ML; Hernández-Pando R
J Dermatol Sci; 2012 Jan; 65(1):19-26. PubMed ID: 22047630
[TBL] [Abstract][Full Text] [Related]
40. Expression of LL-37, human beta defensin-2, and CCR6 mRNA in patients with psoriasis vulgaris.
Li D; Li J; Duan Y; Zhou X
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(4):404-6. PubMed ID: 15587410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
